ENTEROME S.A.
Patent Applications and Registrations
Patent applications and USPTO patent grants for ENTEROME S.A..The latest application filed is for "antigenic peptides for prevention and treatment of cancer".
- ENTEROME S.A. - Paris FR
| Patent | Date |
|---|---|
| Antigenic Peptides For Prevention And Treatment Of Cancer App 20210113678 - CHENE; Laurent ; et al. | 2021-04-22 |
| Immunogenic Compounds For Treatment Of Fibrosis, Autoimmune Diseases And Inflammation App 20210106652 - CHENE; Laurent ; et al. | 2021-04-15 |
| Microbiota Sequence Variants Of Tumor-Related Antigenic Epitopes App 20200256877 - A1 | 2020-08-13 |
| Immunogenic Compounds For Cancer Therapy App 20200113983 - CHENE; Laurent ; et al. | 2020-04-16 |
| Microbiota Sequence Variants Of Tumor-Related Antigenic Epitopes App 20200025774 - CHENE; Laurent ; et al. | 2020-01-23 |
| Immunogenic Compounds For Cancer Therapy App 20190388532 - CHENE; Laurent ; et al. | 2019-12-26 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 